gabexate has been researched along with Dermatitis Medicamentosa in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old Japanese man developed septal panniculitis with eosinophilic infiltration in both forearms and the dorsum of the left hand after a gabexate mesilate intravenous drip infusion for acute pancreatitis through catheters implanted in these sites." | 3.69 | Panniculitis with eosinophilic infiltration due to gabexate mesilate (FOY): possibility of allergic reaction. ( Nakayama, F, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakayama, F | 1 |
1 other study available for gabexate and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Panniculitis with eosinophilic infiltration due to gabexate mesilate (FOY): possibility of allergic reaction.
Topics: Acute Disease; Blood Proteins; Connective Tissue; Cytoplasmic Granules; Drug Eruptions; Eosinophil G | 1997 |